Prevalence and clinical characteristics of patients with metabolic dysfunction-associated fatty liver disease with hepatitis C virus infection-a population-based study.

Dina Attia Shereen Abdel AlemWafaa El-AkelWael Abdel-RazekMohamed EslamYasser Mahrous Fouad Imam Waked

Published in: Alimentary pharmacology & therapeutics (2022)

MAFLD is highly prevalent in patients with HCV infection and has risen over time. This rising prevalence parallels the alarming rise in obesity, diabetes mellitus and hypertension. Early detection of metabolic dysfunction in patients with HCV infection is recommended to prevent MAFLD progression.

Keyphrases

hepatitis c virus
hepatitis c virus infection
risk factors
oxidative stress
blood pressure
metabolic syndrome
insulin resistance
weight loss
human immunodeficiency virus
skeletal muscle
high fat diet induced
physical activity
body mass index
arterial hypertension